Head-To-Head Survey: ReWalk Robotics


ReWalk Robotics and Delcath Systems are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, profitability, earnings and risk. ReWalk Robotics has a beta of 0.79, suggesting that its stock price is 21% less volatile than the S&P 500.



from Biotech News